MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$152,594,000
EPS
-$0.76
Unit: Dollar
Income Statement
2025-09-30
2025-06-30
Research and development
1,143,000
-
General and administrative
151,451,000
-
Formation and operating costs
-
374,857
Total operating expenses
152,594,000
-
Loss from operations
-152,594,000
-374,857
Income on trust account
-
18,080
Interest expense
-
28,345
Net loss and comprehensive loss
-152,594,000
-385,122
Basic EPS
-0.76
-
Diluted EPS
-0.76
-
Basic Average Shares
201,686,617
-
Diluted Average Shares
201,686,617
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DNQAF Income Statement Sankey DiagramSankey diagram visualizing DNQAF income statement for the periodNet loss andcomprehensive loss-$152,594,000 Loss from operations-$152,594,000 Total operatingexpenses$152,594,000 General andadministrative$151,451,000 Research and development$1,143,000

Semnur Pharmaceuticals, Inc. (DNQAF)

Semnur Pharmaceuticals, Inc. (DNQAF)